BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 17534163)

  • 21. Multiple myeloma and Waldenström's macroglobulinemia terminating in acute leukemia. Review with emphasis on karyotypic and ultrastructural abnormalities.
    Rosner F; Grünwald HW
    N Y State J Med; 1980 Mar; 80(4):558-70. PubMed ID: 6767209
    [No Abstract]   [Full Text] [Related]  

  • 22. [Molecular basis of Waldenström macroglobulinemia].
    Sevčíková S; Novák L; Kubiczková L; Dementyeva E; Ríhová L; Hájek R
    Klin Onkol; 2012; 25(6):413-20. PubMed ID: 23301642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytogenetic studies of some hemopathies].
    Vulpis G
    Omnia Med Ther; 1967; 45(1):1-33. PubMed ID: 4971275
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
    Atrash S; Zhang Q; Papanikolaou X; Stein C; Abdallah AO; Barlogie B
    J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics and molecular profiling of multiple myeloma: novel tools for clinical management?
    Tassone P; Tagliaferri P; Rossi M; Gaspari M; Terracciano R; Venuta S
    Eur J Cancer; 2006 Jul; 42(11):1530-8. PubMed ID: 16820292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia.
    Poulain S; Roumier C; Venet-Caillault A; Figeac M; Herbaux C; Marot G; Doye E; Bertrand E; Geffroy S; Lepretre F; Nibourel O; Decambron A; Boyle EM; Renneville A; Tricot S; Daudignon A; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
    Clin Cancer Res; 2016 Mar; 22(6):1480-8. PubMed ID: 26490317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chromosome abnormalities in paraproteinemia with special reference to the idiopathic forms].
    Siebner H; Spengler GA
    Helv Med Acta Suppl; 1967 May; 47():138. PubMed ID: 4999868
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene expression profiling and multiple myeloma.
    Shaughnessy J; Zhan F; Barlogie B; Stewart AK
    Best Pract Res Clin Haematol; 2005; 18(4):537-52. PubMed ID: 16026736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with inv(16)(p13q22) as a sole genetic abnormality.
    Frater JL; Mirkhaef M; Batanian JR
    Cancer Genet Cytogenet; 2007 Apr; 174(2):161-5. PubMed ID: 17452259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.
    Lombardi L; Poretti G; Mattioli M; Fabris S; Agnelli L; Bicciato S; Kwee I; Rinaldi A; Ronchetti D; Verdelli D; Lambertenghi-Deliliers G; Bertoni F; Neri A
    Genes Chromosomes Cancer; 2007 Mar; 46(3):226-38. PubMed ID: 17171682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The karyotype in paraproteinemias].
    Riva G; Spengler GA; Siebner H
    Minerva Med; 1971 May; 62(41):2081-4. PubMed ID: 4996374
    [No Abstract]   [Full Text] [Related]  

  • 32. [Characteristics of chromosomal complexes in patients with narrow-band (monoclonal) gammapathies (literature survey)].
    Zakharova AV
    Probl Gematol Pereliv Krovi; 1975 Feb; 20(2):53-62. PubMed ID: 810791
    [No Abstract]   [Full Text] [Related]  

  • 33. [Familial immunoglobulin anomalies in paraproteinemic diseases].
    Melli G; Mazzei D; Invernizzi F
    Minerva Med; 1972 Mar; 63(22):1257-73. PubMed ID: 4623011
    [No Abstract]   [Full Text] [Related]  

  • 34. Insights from the gene expression profiling of multiple myeloma.
    Claudio JO; Masih-Khan E; Stewart AK
    Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.
    Carulli G; Ciancia EM; Azzarà A; Ottaviano V; Grassi S; Ciabatti E; Ferreri MI; Rocco M; Marini A; Petrini M
    J Clin Exp Hematop; 2013; 53(1):29-36. PubMed ID: 23801131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling defines a high-risk entity of multiple myeloma.
    Zhan FH; Barlogie B; John D S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):191-203. PubMed ID: 17478923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
    Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
    Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chromosome abnormalities during chronic lymphoid leukemia, malignant lymphoreticular process and Kahler's disease].
    Broustet A; Meuge C; Legrand E
    Nouv Rev Fr Hematol; 1970; 10(1):91-9. PubMed ID: 4246339
    [No Abstract]   [Full Text] [Related]  

  • 39. [Multiple primary neoplasms in patients with multiple myeloma and primary macroglobulinemia].
    Fujii H; Yashige H; Shizumi Y; Kitagawa Y; Horishi M; Suyama Y; Miyoshi M
    Gan No Rinsho; 1989 Nov; 35(14):1661-4. PubMed ID: 2512395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytogenetic and molecular basis of multiple myeloma].
    Taniwaki M; Matsumoto Y
    Nihon Rinsho; 2007 Dec; 65(12):2179-86. PubMed ID: 18069258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.